ストックスクリーナーアプリを入手
1.81
1.90%
-0.03
前日終値:
$1.84
開ける：
$1.84
24時間の取引高:
142.89K
Relative Volume:
0.11
時価総額：
$114.50M
収益：
$139.77M
当期純損益:
$-97.62M
株価収益率:
-1.1456
EPS:
-1.58
ネットキャッシュフロー:
$-61.71M
1週間 パフォーマンス:
+3.74%
1か月 パフォーマンス:
+12.11%
6か月 パフォーマンス:
+8.08%
1年 パフォーマンス:
-44.12%
1日の値動き範囲:
$1.80
$1.86
1週間の範囲:
$1.615
$1.89
52週間の値動き範囲:
$0.9897
$3.25
Macrogenics Inc Stock (MGNX) Company Profile
名前
Macrogenics Inc
セクター
電話
301-251-5172
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
MGNX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MGNX
Macrogenics Inc
|
1.81 | 116.40M | 139.77M | -97.62M | -61.71M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
478.12 | 120.31B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
757.36 | 81.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
847.30 | 53.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
352.31 | 46.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
347.95 | 37.20B | 4.98B | 69.59M | 525.67M | 0.5197 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-17 | 再開されました | Barclays | Overweight |
| 2024-11-07 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-01 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-07-31 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2024-07-31 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-05-10 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-05-10 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-04-26 | 開始されました | B. Riley Securities | Buy |
| 2024-04-09 | アップグレード | TD Cowen | Hold → Buy |
| 2024-03-04 | 繰り返されました | BTIG Research | Buy |
| 2024-02-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-12-20 | アップグレード | Citigroup | Neutral → Buy |
| 2023-11-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-11-22 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-11-14 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2022-07-18 | ダウングレード | SMBC Nikko | Outperform → Neutral |
| 2022-07-11 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-05-04 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-02-28 | アップグレード | Citigroup | Neutral → Buy |
| 2022-02-11 | 開始されました | BMO Capital Markets | Outperform |
| 2022-02-04 | 開始されました | SMBC Nikko | Outperform |
| 2021-11-17 | 再開されました | Guggenheim | Buy |
| 2021-10-19 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | アップグレード | Barclays | Underweight → Overweight |
| 2020-12-22 | 再開されました | H.C. Wainwright | Buy |
| 2020-08-03 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-06-01 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-05-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-04 | 開始されました | Barclays | Underweight |
| 2019-12-19 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-12-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-11-21 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-20 | 再開されました | Guggenheim | Neutral |
| 2019-05-03 | アップグレード | Wedbush | Neutral → Outperform |
| 2019-04-12 | 開始されました | Guggenheim | Neutral |
| 2019-02-07 | アップグレード | Citigroup | Sell → Buy |
| 2019-02-07 | ダウングレード | Wedbush | Outperform → Neutral |
| 2019-02-06 | アップグレード | Raymond James | Underperform → Mkt Perform |
| 2019-02-04 | ダウングレード | Citigroup | Neutral → Sell |
| 2018-12-10 | ダウングレード | Raymond James | Outperform → Underperform |
| 2018-09-10 | 再開されました | BTIG Research | Buy |
| 2018-05-31 | 開始されました | Evercore ISI | Outperform |
| 2018-03-05 | 開始されました | H.C. Wainwright | Buy |
| 2017-03-31 | 開始されました | Raymond James | Outperform |
すべてを表示
Macrogenics Inc (MGNX) 最新ニュース
Aug Swings: Whats the fair value of Humacyte Inc Equity Warrant stockJuly 2025 Volume & Daily Chart Pattern Signals - baoquankhu1.vn
Retail Trends: What is the next catalyst for MacroGenics IncQuarterly Profit Report & Advanced Swing Trade Entry Plans - baoquankhu1.vn
MacroGenics (NASDAQ:MGNX) Stock Crosses Below 200-Day Moving Average – Should You Sell? - Defense World
MacroGenics (NASDAQ:MGNX) Stock Crosses Below 200-Day Moving AverageShould You Sell? - MarketBeat
Weekly Trades: Is MacroGenics Inc attractive for institutional investorsWeekly Market Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Will MacroGenics Inc outperform the market in YEAR2025 Biggest Moves & High Conviction Trade Alerts - baoquankhu1.vn
MacroGenics, Inc. (NASDAQ:MGNX) Given Average Rating of "Hold" by Analysts - MarketBeat
[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Is Via Renewables Inc impacted by rising ratesWeekly Trend Recap & Long-Term Growth Stock Strategies - baoquankhu1.vn
MacroGenics (NASDAQ:MGNX) Stock Price Crosses Above 50 Day Moving Average – What’s Next? - Defense World
MacroGenics (NASDAQ:MGNX) Stock Price Crosses Above 50 Day Moving AverageWhat's Next? - MarketBeat
Meme Stocks: Is MacroGenics Inc attractive for institutional investorsLayoff News & Smart Money Movement Alerts - baoquankhu1.vn
Will MacroGenics Inc. stock benefit from green energy trendsJuly 2025 Sentiment & Consistent Income Trade Ideas - Улправда
How supply chain issues affect MacroGenics Inc. stockQuarterly Performance Summary & Weekly High Return Opportunities - Улправда
Market Leaders: How supply chain issues affect MacroGenics Inc. stockWeekly Investment Report & Step-by-Step Trade Execution Guides - ulpravda.ru
Will MacroGenics Inc. stock gain from government policiesEarnings Overview Summary & Risk Controlled Swing Alerts - Улправда
How MacroGenics Inc. stock performs in rising dollar environment2026 world cup usa national team quarterfinals young talents pressing system odds analysis breakdown - ulpravda.ru
There's No Escaping MacroGenics, Inc.'s (NASDAQ:MGNX) Muted Revenues Despite A 26% Share Price Rise - simplywall.st
MacroGenics (NASDAQ:MGNX) Cut to “Hold” at Zacks Research - Defense World
MacroGenics (NASDAQ:MGNX) Rating Lowered to "Hold" at Zacks Research - MarketBeat
MacroGenics (NASDAQ:MGNX) Shares Pass Above 50 Day Moving Average – Should You Sell? - Defense World
MacroGenics (NASDAQ:MGNX) Shares Pass Above 50 Day Moving AverageShould You Sell? - MarketBeat
MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is MacroGenics Inc. stock positioned well for digital economyJuly 2025 Final Week & Weekly Breakout Watchlists - Улправда
Will MacroGenics Inc. stock attract more institutional investors2025 Growth vs Value & Technical Confirmation Alerts - DonanımHaber
MacroGenics, Inc.(NasdaqGS: MGNX) dropped from NASDAQ Biotechnology Index - marketscreener.com
Macrogenics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Is MacroGenics Inc. stock a dividend growth opportunityJuly 2025 Action & Weekly Market Pulse Alerts - Улправда
MacroGenics Insider Ups Holding By 909% During Year - simplywall.st
Analyzing MacroGenics Stock: To Buy Or Wait? - StocksToTrade
EcoR1 Capital LLC Purchases New Shares in MacroGenics, Inc. $MGNX - MarketBeat
Will MacroGenics Inc stock attract more institutional investorsRecession Risk & Real-Time Volume Triggers - moha.gov.vn
MacroGenics (NASDAQ:MGNX) Stock Passes Below 200 Day Moving AverageHere's What Happened - MarketBeat
Reviewing MacroGenics (NASDAQ:MGNX) & Exagen (NASDAQ:XGN) - Defense World
Wall Street analysts’ outlook for Macrogenics Inc (MGNX) - setenews.com
What analysts say about MacroGenics Inc stockReal-Time Stock Alerts & Free Tremendous Portfolio Expansion - earlytimes.in
MacroGenics (NASDAQ:MGNX) Shares Cross Below 200-Day Moving AverageHere's What Happened - MarketBeat
MacroGenics (NASDAQ:MGNX) Shares Cross Below 200-Day Moving Average – Here’s What Happened - Defense World
IM Cannabis (NASDAQ:IMCC) & MacroGenics (NASDAQ:MGNX) Head to Head Survey - Defense World
Macrogenics (MGNX) Stock Analysis Report | Financials & Insights - Benzinga
MGNX (Macrogenics) EPS without NRI : $-1.20 (TTM As of Sep. 2025) - GuruFocus
MGNX (Macrogenics) Operating Cash Flow per Share : $-2.58 (TTM As of Sep. 2025) - GuruFocus
MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference - Enidnews.com
Taking the lead: Macrogenics Inc (MGNX) - Setenews
MacroGenics (Nasdaq: MGNX) to Present at 8th Evercore Healthcare Conference Fireside Chat - Stock Titan
Is MacroGenics Inc. stock cheap at current valuationEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Is MacroGenics Inc. stock positioned for digital transformation2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com
Will MacroGenics Inc. stock recover faster than peersForecast Cut & Free Growth Oriented Trading Recommendations - newser.com
Macrogenics Inc (MGNX) 財務データ
収益
当期純利益
現金流量
EPS
1.31%
3.45%
大文字化:
|
ボリューム (24 時間):